Poltreg SA
Poltreg SA maintains a strong liquidity position, with cash and equivalents amounting to 45.76 million PLN, representing 38.7% of total assets. The company's liquidity FPT (free cash flow to total assets) is negative at -8.9%, indicating ongoing cash outflows from operations. The current ratio of 4.94 suggests the company has sufficient short-term assets to cover its liabilities multiple times over. Profitability metrics are negative, with a return on equity of -3.98% and a return on assets of -2.84%. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets. The gross profit of -1.95 million PLN and operating income of -3.82 million PLN further underscore the company's unprofitable operations. Geographically, Poltreg SA's revenue is concentrated in a single jurisdiction, as disclosed revenue is reported without segment breakdown. This lack of diversification increases exposure to local economic and regulatory risks. The company's revenue of 100 million PLN is derived from a single revenue stream, with no disclosed geographic or product diversification. The company's growth trajectory is uncertain, with no disclosed revenue growth or decline in the most recent period. Analysts have assigned a mean price target of 67.30 PLN, with a single "buy" recommendation and no "strong buy" or "hold" ratings. The absence of analyst optimism suggests limited confidence in the company's near-term performance. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.1 indicates a conservative capital structure, with long-term debt at 8.01 million PLN and total equity at 84.28 million PLN. No dilution sources were identified in recent filings, and the dilution potential is assessed as low. Recent events include the publication of the latest financial results, which show continued losses and negative cash flows. No material regulatory or litigation events were disclosed in the most recent filings. The company's capital expenditure of -7.44 million PLN reflects ongoing investment in operations, but the negative free cash flow of -10.52 million PLN indicates that these investments are not yet generating positive returns.
Business. Poltreg SA is a biotechnology company focused on healthcare diagnostics, primarily generating revenue through the development and commercialization of diagnostic solutions.
Classification. Poltreg SA is classified under the Healthcare economic sector, within the Pharmaceuticals & Medical Research business sector, and the Biotechnology & Medical Research industry, with a classification confidence of 0.92.
- Poltreg SA has a strong liquidity position with 45.76 million PLN in cash and equivalents.
- The company is unprofitable, with negative returns on equity and assets.
- Revenue is concentrated in a single jurisdiction, increasing exposure to local risks.
- Analysts have assigned a mean price target of 67.30 PLN, with limited optimism.
- The company maintains a conservative capital structure with low debt and no immediate dilution risk.
- --
- # RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.